ArticleJCO precision oncology2022

Implementation of the Time-to-Event Continuous Reassessment Method Design in a Phase I Platform Trial Testing Novel Radiotherapy-Drug Combinations-CONCORDE.

Katrina Walker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.